Chemotargets Clarity Software (Toxicology)

The Food and Drug Administration is forecasting the acquisition of Chemotargets Clarity Software to support its in silico receptor binding program focused on toxicology evaluations. The software will enable advanced computational modeling to assess potential toxicological interactions of compounds with biological receptors, enhancing the agency’s ability to predict adverse effects without relying solely on empirical testing. This initiative aligns with HFP Priority #413, reflecting a strategic effort to modernize and expedite safety assessments through targeted digital tools. The procurement is classified under NAICS code 511210, indicating it falls within the software publishing sector, and is posted as a forecast on the HHS OSDBU portal with no solicitation number assigned yet. The point of contact for program-related inquiries is the HFP Acquisition Liaison at hfpacquisitions@fda.hhs.gov, while the contracting officer position remains to be determined. There is no specified set-aside status, location, or delivery details at this stage, and the anticipated contract type or fiscal year remains unconfirmed; the posting serves as a pre-solicitation notice to inform industry of an upcoming opportunity.